跳至主要内容
临床试验/NCT02007603
NCT02007603已完成3 期

Multiple-dose Pharmacokinetics of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid During Haemodialysis in Longterm Haemodialysis Patients

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
16
试验地点
1
主要终点
Influence of hemodialysis on the area under concentration curve of ampicillin/sulbactam and amoxicillin / clavulanic acid plasma concentration levels.

研究概览

简要总结

The study will be conducted to investigate the pharmacokinetics of ampicillin / sulbactam and amoxicillin/clavulanic acid during intermittent haemodialysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Suspected or proven bacterial infection requiring parenteral antibiotic therapy.
  • Renal replacement therapy (HD)

排除标准

  • Known hypersensitivity to ampicillin / sulbactam, amoxicillin / clavulanic acid or other beta-lactames, or severe hypersensitivity (anaphylactic reaction) to beta-lactam antibacterial agents.
  • An expected survival of less than two days.
  • Known pregnancy
  • Co-administration of one of the following drugs: probenecid which cannot be discontinued for the duration of the study
  • Ampicillin / sulbactam respectively amoxicillin / clavulanic acid as monotherapy for resistant species or fungal infections.
  • Other reasons opposing the study participation on the discretion of the investigators.

研究组 & 干预措施

Ampicillin / sulbactam

Experimental

Patients are randomized to the ampicillin / sulbactam arm. Pharmacokinetic samples will be taken during multiple hemodialysis sessions.

干预措施: Ampicillin / sulbactam (Drug)

Ampicillin / sulbactam

Experimental

Patients are randomized to the ampicillin / sulbactam arm. Pharmacokinetic samples will be taken during multiple hemodialysis sessions.

干预措施: Blooddraws for pharmacokinetic profiling (Procedure)

Amoxicillin / clavulanic acid

Experimental

Patients are randomized to the amoxicillin / clavulanic acid arm. Pharmacokinetic samples will be taken during multiple hemodialysis sessions.

干预措施: Administration of Amoxicillin / clavulanic acid (Drug)

Amoxicillin / clavulanic acid

Experimental

Patients are randomized to the amoxicillin / clavulanic acid arm. Pharmacokinetic samples will be taken during multiple hemodialysis sessions.

干预措施: Blooddraws for pharmacokinetic profiling (Procedure)

结局指标

主要结局

Influence of hemodialysis on the area under concentration curve of ampicillin/sulbactam and amoxicillin / clavulanic acid plasma concentration levels.

时间窗: day 15

Pharmacokinetic samples are drawn on multiple timepoints from each patient during his participation.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Florian Thalhammer

a.o.Univ.-Prof. Dr.

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Concentration of ampicillin / sulbactam and amoxicillin / clavulanic acid in the blood during renal replacement therapy in longterm renal replacent therapy patientsSuspected or proven bacterial infection requiring therapy with broad spectrum antibioticsMedDRA version: 14.1Level: LLTClassification code 10042196Term: Streptococcus pneumoniae secondary bacterial infection of acute bronchitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10053021Term: Gram-positive bacterial infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10035649Term: Pneumococcal secondary bacterial infection of acute bronchitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10004038Term: Bacterial infection due to streptococcus, group CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10004039Term: Bacterial infection due to streptococcus, group DSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.0Level: LLTClassification code 10004031Term: Bacterial infection due to other gram-negative organismsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: HLTClassification code 10004047Term: Bacterial infections NECSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: PTClassification code 10060945Term: Bacterial infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10004042Term: Bacterial infection due to unspecified streptococcusSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10004037Term: Bacterial infection due to streptococcus, group BSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10054278Term: Bacterial infection due to streptococcus, group FSys
EUCTR2012-001496-36-ATMedizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme16
Enrolling By Invitation
1 期
Oral Amoxicillin and Cephalexin PK/PD in NeonatesNeonatal Infection
NCT04916951University of Colorado, Denver60
已完成
不适用
Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS PatientsSalmonella InfectionsHIV Infections
NCT00002052University of Southern California
已完成
不适用
Effect of Bifidobacterium Breve PRL2020 (an Amoxicillin-clavulanate-resistant Strain) on Gastrointestinal Symptoms and Gut Microbiota Composition in Children Treated With Amoxicillin or Amoxicillin/ClavulanateBacterial Infections
NCT05840588Liaquat University of Medical & Health Sciences121
招募中
不适用
Different Amoxicillin Treatment Regimens in Erythema Migrans PatientsErythema Migrans
NCT03966014University Medical Centre Ljubljana510